Discussing Preimplantation Genetic Diagnosis
Preimplantation genetic diagnosis allows women of childbearing age to select embryos that do not have genetic mutations.
When talking about genetic testing in patients with breast cancer, it is important to frame it as a personal choice that can benefit both the patient and their family, said Kristin Rojas, MD, breast surgical oncologist affiliated with the Brooklyn Breast Program at Maimonides Medical Center.
While more patients and providers are addressing the topic of genetic testing, preimplantation genetic diagnosis for those who are hoping to have children is not talked about as much. Through this process, clinicians can select embryos that do not have the BRCA1 or BRCA2 mutation to be used in reproduction.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.
